Tags

Type your tag names separated by a space and hit enter

Cutaneous Involvement of Hematologic Malignancies.
Hematol Oncol Clin North Am. 2019 02; 33(1):163-172.HO

Abstract

In reviewing cutaneous manifestations of various hematologic malignancies, the authors focus on secondary cutaneous lymphomas and cutaneous manifestations of histiocyte disorders. Secondary cutaneous lymphomas are defined as skin lesions that develop secondary to infiltration by systemic lymphomas with predominantly extracutaneous involvement. In their review of histiocytic disorders with skin involvement, the authors focus on Langerhans cell histiocytosis and Rosai-Dorfman disease. Their review emphasizes the histology, pathophysiology, clinical presentation, prognosis, and treatments available for these diseases.

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Kaddis N
Department of Hematology and Oncology, Dana-Farber Cancer Institute at St Elizabeth's Medical Center, 736 Cambridge Street, Brighton, MA 02135, USA.
Fisher D
Lymphoma Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Jacobsen ED
Lymphoma Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: Eric_Jacobsen@dfci.harvard.edu.

MeSH

BiomarkersDiagnosis, DifferentialDisease ManagementHematologic NeoplasmsHumansNeoplasms, Second PrimarySkinSkin DiseasesSkin Neoplasms

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

30497673

Citation

Kaddis, Nancy, et al. "Cutaneous Involvement of Hematologic Malignancies." Hematology/oncology Clinics of North America, vol. 33, no. 1, 2019, pp. 163-172.
Kaddis N, Fisher D, Jacobsen ED. Cutaneous Involvement of Hematologic Malignancies. Hematol Oncol Clin North Am. 2019;33(1):163-172.
Kaddis, N., Fisher, D., & Jacobsen, E. D. (2019). Cutaneous Involvement of Hematologic Malignancies. Hematology/oncology Clinics of North America, 33(1), 163-172. https://doi.org/10.1016/j.hoc.2018.08.005
Kaddis N, Fisher D, Jacobsen ED. Cutaneous Involvement of Hematologic Malignancies. Hematol Oncol Clin North Am. 2019;33(1):163-172. PubMed PMID: 30497673.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cutaneous Involvement of Hematologic Malignancies. AU - Kaddis,Nancy, AU - Fisher,David, AU - Jacobsen,Eric D, PY - 2018/12/1/entrez PY - 2018/12/1/pubmed PY - 2020/5/19/medline KW - Histiocyte disorders KW - Langerhans cell histiocytosis (LCH) KW - Rosai-Dorfman disease (RDD) KW - Secondary cutaneous lymphoma SP - 163 EP - 172 JF - Hematology/oncology clinics of North America JO - Hematol Oncol Clin North Am VL - 33 IS - 1 N2 - In reviewing cutaneous manifestations of various hematologic malignancies, the authors focus on secondary cutaneous lymphomas and cutaneous manifestations of histiocyte disorders. Secondary cutaneous lymphomas are defined as skin lesions that develop secondary to infiltration by systemic lymphomas with predominantly extracutaneous involvement. In their review of histiocytic disorders with skin involvement, the authors focus on Langerhans cell histiocytosis and Rosai-Dorfman disease. Their review emphasizes the histology, pathophysiology, clinical presentation, prognosis, and treatments available for these diseases. SN - 1558-1977 UR - https://www.unboundmedicine.com/medline/citation/30497673/Cutaneous_Involvement_of_Hematologic_Malignancies_ DB - PRIME DP - Unbound Medicine ER -